Recent 8-K filings for EHSI

• August 5, 2026, 2:44 PM ET debt materiality 0.50 neutral item 1.01item 9.01

  Elite Health Systems enters $525K subordinated note with CEO; grants warrants for 110,526 shares

  $525,000 subordinated note from CEO Dr. Prasad Jeereddi, due July 31, 2027, 10% interest, 2% prepayment penalty.

• July 10, 2026, 2:29 PM ET other material materiality 0.70 negative item 8.01

  Elite Health Systems board authorizes strategic alternatives review amid competitive and regulatory challenges

  Board authorized management to explore strategic alternatives including sale, merger, financing, or asset dispositions.

• November 5, 2025, 6:59 PM ET M&A materiality 0.65 positive item 5.07

  Elite Health Systems shareholders approve acquisition of PSS and share increase to 50M

  All six proposals passed at Special Meeting on Sept 26, 2025, with quorum of 14.7M votes.

• September 29, 2025, 7:59 PM ET M&A materiality 0.55 neutral item 1.01

  Elite Health Systems to acquire PSS in all-stock deal worth 3.16M shares

  Acquires 100% of Physician Support Systems from stockholders including CEO Dr. Prasad Jeereddi (46% owner).

• September 2, 2025, 7:59 PM ET other material materiality 0.70 positive item 1.01

  Elite Health Plan subsidiary signs CMS contract for Medicare Advantage Plan, onboarding Oct 2025

  On Aug 28, 2025, Elite Health Plan executed CMS contract to operate as an MA/MA-PD organization.

• July 31, 2025, 7:59 PM ET leadership materiality 0.50 neutral item 5.02

  Elite Health Systems appoints Dr. Haranath Policherla as director and Ken Minor as CFO

  Dr. Haranath Policherla, age 67, appointed non-executive director effective July 26, 2025.

• July 3, 2025, 7:59 PM ET M&A materiality 0.65 neutral item 3.02item 8.01

  Elite Health Systems commences $2M-$5M private placement; enters LOI to acquire PSS for 3.16M shares

  Private placement of common stock at $0.95/share for gross proceeds of $2M to $5M; proceeds to fund Elite Health Plan and PSS integration.

• June 9, 2025, 7:59 PM ET other materiality 0.10 neutral item 1.01

  Elite Health Systems to change OTC ticker from USNU to EHSI effective June 10, 2025

  FINRA notified Elite Health Systems on June 9, 2025 that the ticker symbol change request is fully processed.

• June 5, 2025, 7:59 PM ET regulatory materiality 0.65 neutral item 1.01

  Elite Health Systems subsidiary gets conditional CMS approval for CY 2026 Medicare Advantage

  Elite Health Plan received conditional CMS approval for its CY 2026 Medicare Advantage/MA-PD application on June 3, 2025.

• May 30, 2025, 7:59 PM ET regulatory materiality 0.65 positive item 1.01

  Elite Health Systems subsidiary awarded full-service health plan license in California

  Elite Health Plan, wholly owned subsidiary, awarded full-service health care service plan license under Knox-Keene Act on May 29, 2025.

• December 2, 2024, 6:59 PM ET other material materiality 0.40 neutral item 1.01item 8.01

  Elite Health Systems ups private placement to $5.5M, issues 480K shares for compensation

  Board amended private placement terms to raise up to $5,500,000; $5.05M raised to date at $0.50/share.

• October 3, 2024, 7:59 PM ET other material materiality 0.30 neutral item 5.03item 8.01item 9.01 ◈ Governance Changes

  Elite Health Systems (f/k/a U.S. Neurosurgical Holdings) changes name, applies for new OTC ticker

  Name changed to Elite Health Systems, Inc. effective September 30, 2024 via Delaware certificate of amendment.

• July 12, 2024, 7:59 PM ET leadership materiality 0.65 neutral item 1.01item 5.02 ◈ executive_change ×3

  U.S. Neurosurgical Holdings names Dr. Prasad Jeereddi CEO; expands private placement to $5M

  Charles H. Merriman resigned from the Board effective July 10, 2024; no disagreement cited.

• January 18, 2024, 6:59 PM ET other material materiality 0.60 neutral item 1.01item 9.01 ◈ Material Agreements

  USNU raises $1M in initial close of up to $2M private placement at $0.50/share

  Initial closing of private placement raised $1,000,000 from accredited investors at $0.50 per share; second close up to $1,000,000 expected within a month.

• November 28, 2023, 6:59 PM ET M&A materiality 0.50 neutral item 1.01item 8.01item 9.01 ◈ Material Agreements

  USNU acquires remaining 15% of subsidiary USN, issuing 1.39M shares in share exchange

  USNU issued 1,392,739 new shares to minority holders of USN, making USN a wholly-owned subsidiary.

• April 19, 2023, 7:59 PM ET leadership materiality 0.25 neutral item 5.02 ◈ executive_change

  William St. Lawrence appointed non-executive director of U.S. Neurosurgical Holdings, effective April 17, 2023

  Receives 50,000 shares of common stock as director compensation.

• September 13, 2022, 7:59 PM ET other material materiality 0.60 neutral item 4.01item 9.01

  U.S. NeuroSurgical swaps auditor Aronson LLC for AJSH & Co LLP; notes material weaknesses

  Aronson LLC resigned as independent accountant effective Sept 7, 2022; AJSH & Co LLP engaged Aug 22, 2022 as successor.

• August 4, 2022, 7:59 PM ET other material materiality 0.75 negative

  U.S. NeuroSurgical Holdings restates Q1 2022 financials; prior statements not reliable

  On August 3, 2022, management determined Q1 2022 balance sheet failed to reflect changes from restated FY2021 10-K/A.

• June 2, 2022, 7:59 PM ET other material materiality 0.70 negative item 4.02

  U.S. NeuroSurgical Holdings to restate 2021 financials due to $250K tax liability error

  2021 consolidated financial statements no longer reliable; restatement required.

• October 6, 2021, 7:59 PM ET M&A materiality 0.65 neutral item 1.01item 9.01

  USN subsidiary to acquire Elite Health Plan for 15% stake in unit

  USN (wholly owned by USNU) issues 300 new shares to Elite Health shareholders, representing 15% of USN post-closing.

Executive changes

Materiality & sentiment trend

Max materiality 0.75 · Median 0.62 · Most common event other_material

3 positive 3 negative 14 neutral

source · EHSI on sec.gov